glp-1 dialysis Association of glucagon-like peptide-1 receptor agonists with cardiovascular and kidney outcomes in type 2 diabetic kidney transplant recipients | Cardiovascular Diabetology Renoprotective mechanisms of glucagon-like peptide-1

Common skin changes with weight loss medications include: Crepey Dull Inflamed/sensitive Intensified lines and wrinkles Sagging Shallow Sunken/hollowed HOW WEIGHT LOSS MEDICATIONS IMPACT SKIN BEYOND VOLUME LOSS Beyond volume loss, many of my clients display compromised skin barrier, dehydrated skin, and inflammation

The definitive informational guide for Allulose in South Africa

Discover benefits, side effects, and whos a good candidate.

Rising demand for GLP-1 weight-loss drugs like Ozempic is forcing employers to rethink coverage

If prescribed to treat Type 2 diabetes: If a GLP-1 is prescribed by a healthcare provider to treat type-2 diabetes, the HSA can be used to pay the expense on a tax-free basis

Observing rs-fMRI, the functional brain connectivity in GLP-1R KO mice was significantly lower than that in the WT group (p=0.0032 for gFCD, p=0.0002 for whole-brain correlation, p<0.0001 for ALFF)